{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:16:41Z","timestamp":1792613801371,"version":"4.5.0"},"reference-count":77,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,12,29]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Functional dyspepsia (FD) is a chronic disorder that is difficult to treat.\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      may contribute to its pathophysiology. A Cochrane review from 2006 suggested that eradication therapy was beneficial, but there have been numerous randomised controlled trials (RCTs) published since. We evaluated impact of eradication therapy on both cure and improvement of FD, as well as whether any benefit was likely to arise from eradication of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      We searched the medical literature through October 2021 to identify RCTs examining efficacy of eradication therapy in\n                      <jats:italic>H. pylori<\/jats:italic>\n                      -positive adults with FD. The control arm received antisecretory therapy or prokinetics, with or without placebo antibiotics, or placebo alone. Follow-up was for \u22653 months. We pooled dichotomous data to obtain a relative risk (RR) of symptoms not being cured or symptoms not improving with a 95% CI. We estimated the number needed to treat (NNT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-nine RCTs recruited 6781\n                      <jats:italic>H<\/jats:italic>\n                      .\n                      <jats:italic>pylori<\/jats:italic>\n                      -positive patients with FD. Eradication therapy was superior to control for symptom cure (RR of symptoms not being cured=0.91; 95%\u2009CI 0.88 to 0.94, NNT=14; 95%\u2009CI 11 to 21) and improvement (RR of symptoms not improving=0.84; 95%\u2009CI 0.78 to 0.91, NNT=9; 95%\u2009CI 7 to 17). There was no significant correlation between eradication rate and RR of FD improving or being cured (Pearson correlation coefficient=\u22120.23, p=0.907), but the effect was larger in patients with successful eradication of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      than with unsuccessful eradication (RR=0.65; 95%\u2009CI 0.52 to 0.82, NNT=4.5, 95%\u2009CI 3 to 9). Adverse events (RR=2.19; 95% 1.10 to 4.37) and adverse events leading to withdrawal (RR=2.60; 95%\u2009CI 1.47 to 4.58) were more common with eradication therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      There is high quality evidence to suggest that\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication therapy leads to both cure and improvement in FD symptoms, although the benefit is modest.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2021-326583","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T13:25:52Z","timestamp":1641993952000},"page":"1967-1975","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":77,"title":["Efficacy of\n                    <i>Helicobacter pylori<\/i>\n                    eradication therapy for functional dyspepsia: updated systematic review and meta-analysis"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-4359","authenticated-orcid":false,"given":"Alexander C","family":"Ford","sequence":"first","affiliation":[{"name":"Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"Leeds Institute of Medical Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Tsipotis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios I","family":"Leontiadis","sequence":"additional","affiliation":[{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"2025120618025119000_71.10.1967.1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"2025120618025119000_71.10.1967.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"2025120618025119000_71.10.1967.3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/apt.16006","article-title":"Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria","volume":"52","author":"Barberio","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120618025119000_71.10.1967.4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"2025120618025119000_71.10.1967.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099846"},{"key":"2025120618025119000_71.10.1967.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04640.x"},{"key":"2025120618025119000_71.10.1967.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.05.021"},{"key":"2025120618025119000_71.10.1967.8","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2014.18","article-title":"Medication risk-taking behavior in functional dyspepsia patients","volume":"6","author":"Lacy","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"2025120618025119000_71.10.1967.9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12355"},{"key":"2025120618025119000_71.10.1967.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1501505"},{"key":"2025120618025119000_71.10.1967.11","first-page":"33","article-title":"The prevalence of Helicobacter pylori infection in different countries","volume":"9 Suppl 2","author":"Pounder","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120618025119000_71.10.1967.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.05.031"},{"key":"2025120618025119000_71.10.1967.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307843"},{"key":"2025120618025119000_71.10.1967.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.2126_1.x"},{"key":"2025120618025119000_71.10.1967.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02236-4"},{"key":"2025120618025119000_71.10.1967.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38702.662546.55"},{"key":"2025120618025119000_71.10.1967.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392601"},{"key":"2025120618025119000_71.10.1967.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910073411502"},{"key":"2025120618025119000_71.10.1967.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01014.x"},{"key":"2025120618025119000_71.10.1967.20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0002-9270(03)00432-5","article-title":"Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia","volume":"98","author":"Veldhuyzen van Zanten","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2025120618025119000_71.10.1967.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7262.659"},{"key":"2025120618025119000_71.10.1967.22","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","volume":"2","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618025119000_71.10.1967.23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2025120618025119000_71.10.1967.24","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36024"},{"key":"2025120618025119000_71.10.1967.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.015"},{"key":"2025120618025119000_71.10.1967.26","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.512"},{"key":"2025120618025119000_71.10.1967.27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312574"},{"key":"2025120618025119000_71.10.1967.28","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.541"},{"key":"2025120618025119000_71.10.1967.29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318160"},{"key":"2025120618025119000_71.10.1967.30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120618025119000_71.10.1967.31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120618025119000_71.10.1967.32","unstructured":"Higgins JPT , Green S . Cochrane handbook for systematic reviews of interventions: Version 5.1.0, 2011. Available: http:\/\/handbook-5-1.cochrane.org\/ [Accessed updated March 2011]."},{"key":"2025120618025119000_71.10.1967.33","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025120618025119000_71.10.1967.34","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1188"},{"key":"2025120618025119000_71.10.1967.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025120618025119000_71.10.1967.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"},{"key":"2025120618025119000_71.10.1967.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025120618025119000_71.10.1967.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392602"},{"key":"2025120618025119000_71.10.1967.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04037.x"},{"key":"2025120618025119000_71.10.1967.40","first-page":"303","article-title":"Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study","volume":"51","author":"Gisbert","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"2025120618025119000_71.10.1967.41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0025-7753(04)74153-6","article-title":"[Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia]","volume":"122","author":"Gonz\u00e1lez Carro","year":"2004","journal-title":"Med Clin"},{"key":"2025120618025119000_71.10.1967.42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00903.x"},{"key":"2025120618025119000_71.10.1967.43","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.1.40"},{"key":"2025120618025119000_71.10.1967.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04240.x"},{"key":"2025120618025119000_71.10.1967.45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01695.x"},{"key":"2025120618025119000_71.10.1967.46","first-page":"133","article-title":"Effect of eradicating H. pylori on the appearance of esophageal reflux disease: Randomized double blind study","volume":"85","author":"Martinek","year":"2005","journal-title":"Praktikcy Lekar"},{"key":"2025120618025119000_71.10.1967.47","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-3090-6"},{"key":"2025120618025119000_71.10.1967.48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00706.x"},{"key":"2025120618025119000_71.10.1967.49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1157\/13072839","article-title":"[Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial]","volume":"124","author":"Ruiz Garc\u00eda","year":"2005","journal-title":"Med Clin"},{"key":"2025120618025119000_71.10.1967.50","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7187.833"},{"key":"2025120618025119000_71.10.1967.51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000065589","article-title":"Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study","volume":"66","author":"Alizadeh-Naeeni","year":"2002","journal-title":"Digestion"},{"key":"2025120618025119000_71.10.1967.52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01909.x"},{"key":"2025120618025119000_71.10.1967.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1818-x"},{"key":"2025120618025119000_71.10.1967.54","first-page":"221","article-title":"Efficacy of Helicobacter pylori eradication treatment in patients with functional dyspepsia]","volume":"13","author":"Shi","year":"2006","journal-title":"Clinical Medical Journal of China"},{"key":"2025120618025119000_71.10.1967.55","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328317b89e"},{"key":"2025120618025119000_71.10.1967.56","first-page":"559","article-title":"Effect of Helicobacter pylori eradication on functional dyspepsia]","volume":"15","author":"Wu","year":"2010","journal-title":"Chinese Journal of Gastroenterology"},{"key":"2025120618025119000_71.10.1967.57","first-page":"3242","article-title":"Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia","volume":"17","author":"Lan","year":"2011","journal-title":"World J Gastroenterol"},{"key":"2025120618025119000_71.10.1967.58","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.533"},{"key":"2025120618025119000_71.10.1967.59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jgh.12178","article-title":"Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India","volume":"28","author":"Sodhi","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120618025119000_71.10.1967.60","first-page":"747","article-title":"Symptom improvement after Helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study","volume":"6","author":"Xu","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"2025120618025119000_71.10.1967.61","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.11569\/wcjd.v22.i13.1897","article-title":"Relationship between functional dyspepsia and Helicobacter pylori infection","volume":"22","author":"Liu","year":"2014","journal-title":"World Chinese Journal of Digestology"},{"key":"2025120618025119000_71.10.1967.62","first-page":"964","article-title":"Effect of Helicobacter pylori eradication in Iranian patients with functional dyspepsia: a prospective, randomized, placebo-controlled trial","volume":"11","author":"Yazdanbod","year":"2015","journal-title":"Arch Med Sci"},{"key":"2025120618025119000_71.10.1967.63","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310721"},{"key":"2025120618025119000_71.10.1967.64","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618025119000_71.10.1967.65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120618025119000_71.10.1967.66","first-page":"CD009431","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618025119000_71.10.1967.67","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320839"},{"key":"2025120618025119000_71.10.1967.68","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3748\/wjg.v12.i15.2398","article-title":"Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey","volume":"12","author":"Nervi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2025120618025119000_71.10.1967.69","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302240"},{"key":"2025120618025119000_71.10.1967.70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322200"},{"key":"2025120618025119000_71.10.1967.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01501-2"},{"key":"2025120618025119000_71.10.1967.72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.40014.x"},{"key":"2025120618025119000_71.10.1967.73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6483"},{"key":"2025120618025119000_71.10.1967.74","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis","volume":"22","author":"Du","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025120618025119000_71.10.1967.75","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/jcm8091324","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: a meta-analysis by region and H. pylori prevalence","volume":"8","author":"Kang","year":"2019","journal-title":"J Clin Med"},{"key":"2025120618025119000_71.10.1967.76","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"2025120618025119000_71.10.1967.77","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2021-326583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:03:01Z","timestamp":1765072981000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2021-326583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,9,7]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/gutjnl-2021-326583"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2021-326583","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}